Jeff Cunningham - Feb 27, 2025 Form 4 Insider Report for HEALTHSTREAM INC (HSTM)

Role
Chief Technology Officer
Signature
/s/ Jeff Cunningham
Stock symbol
HSTM
Transactions as of
Feb 27, 2025
Transactions value $
-$19,195
Form type
4
Date filed
2/28/2025, 09:29 AM
Previous filing
Oct 31, 2024
Next filing
Mar 21, 2025
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction HSTM Common Stock Holding Options Exercise $0 +2K +7.7% $0.00 28K Feb 27, 2025 Direct F1
transaction HSTM Common Stock Holding Tax liability -$19.2K -593 -2.12% $32.37 27.4K Feb 27, 2025 Direct F2

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction HSTM Restricted Share Units Options Exercise $0 -2K -23.53% $0.00 6.5K Feb 27, 2025 Common Stock 2K $0.00 Direct F3, F4, F5
transaction HSTM Restricted Share Units Award $0 +3.61K $0.00 3.61K Feb 27, 2025 Common Stock 3.61K $0.00 Direct F3, F5, F6
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Shares acquired on vesting of restricted share units.
F2 Shares withheld for payment of tax liability.
F3 Each restricted share unit (RSU) represents the contingent right to receive one share of common stock upon vesting of the unit.
F4 Vesting of these RSUs is contingent upon continued service at the time of vesting and the achievement of certain performance criteria. The performance criteria will be established on an annual basis by the Compensation Committee of the Board of Directors. 15% vest on February 23, 2024 for the period January 1, 2023 through December 31, 2023; 20% vest on February 23, 2025 for the period January 1, 2024 through December 31, 2024; 20% vest on February 23, 2026 for the period January 1, 2025 through December 31, 2025; 20% vest on February 23, 2027 for the period January 1, 2026 through December 31, 2026; and 25% vest on February 23, 2028 for the period January 1, 2027 through December 31, 2027. Vesting is determined based on actual performance. The performance criteria for the period January 1, 2024 through December 31, 2024 was achieved; therefore 20% of the awards vested on February 23, 2025.
F5 Not applicable.
F6 Vesting of these RSUs is contingent upon continued service at the time of vesting and the achievement of certain performance criteria. The performance criteria will be established on an annual basis by the Compensation Committee of the Board of Directors. 15% vest on February 27, 2026 for the period January 1, 2025 through December 31, 2025; 20% vest on February 27, 2027 for the period January 1, 2026 through December 31, 2026; 20% vest on February 27, 2028 for the period January 1, 2027 through December 31, 2027; 20% vest on February 27, 2029 for the period January 1, 2028 through December 31, 2028; and 25% vest on February 27, 2030 for the period January 1, 2029 through December 31, 2029. Vesting will be determined based on actual performance. RSUs that do not vest during a performance period may become eligible for vesting during the next performance period (but not in succeeding periods).